Fibroblast Growth Factor Receptor 3 (FGFR3)-Related
Skeletal Dysplasias
Mutations within the Fibroblast Growth
Factor Receptor 3 (FGFR3) gene have been associated with a number of
skeletal dysplasias including Thanatophoric dysplasia Types I and II,
achondroplasia, hypochondroplasia, as well as non-syndromic craniosynostosis
(NSC). Testing for FGFR3 mutations is available through the Molecular
Diagnostic Laboratory of the Greenwood Genetic Center.
FGFR3 testing is not offered as a panel.
You must specify which condition is clinically suspected. Testing for each
condition must be ordered individually and will be billed separately. If you
request more than one test, please specify the order in which they should be run
or if they should be run simultaneously.
Consult with the laboratory director for more
information regarding FGFR3 analysis.
Specimen requirements:
5 to 10 ml of peripheral blood collected in an EDTA (lavender top) Vacutainer
tube is preferred. The minimal blood needed for reliable DNA isolation is 3 ml.
If necessary, ACD solution A Vacutainer tubes (yellow top) may be submitted.
Please contact the laboratory for more information.
Transport:
Please contact the Molecular Diagnostic Laboratory Coordinator (1-800-473-9411)
for shipping information. The specimen should be kept at room temperature and
delivered via overnight shipping. FedEx is preferred. If shipment is delayed by
one or two days, the specimen should be refrigerated and shipped at room
temperature. Do not freeze the specimen. Samples collected on Friday can be
safely designated for Monday delivery.
Analysis Standards:
Analysis will be complete within 2 weeks of sample receipt. The lab director
assesses the quality and interpretation of results. Technical staff members
independently assess the quality and interpretation of the test. The Greenwood
Genetic Center Molecular Diagnostic Laboratory is CLIA certified and actively
participates in CAP proficiency surveys.
Reporting of results:
Test results with interpretation will be mailed and/or faxed following
completion of the test. Verbal reports will be telephoned to the person(s)
requesting the test when an abnormal test result occurs.
| CPT Codes: |
83890, 83898(x2), 83904(x4), 83912 |
Thanatophoric
dysplasia, type I |
| |
|
|
| |
83890, 83892, 83898, 83909, 83912 |
Thanatophoric dysplasia,
type II |
| |
|
Achondroplasia |
| |
|
Hypochondroplasia |
| |
|
Non-Syndromic Craniosynostosis |
|